101 results
S-8
GOSS
Gossamer Bio Inc
8 Feb 19
Registration of securities for employees
4:46pm
reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit us and our … policy as expressed in the Securities Act and is therefore unenforceable. There is no pending litigation or proceeding naming any of our directors
S-1
EX-10.14
GOSS
Gossamer Bio Inc
21 Dec 18
IPO registration
4:39pm
to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against … in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement, by litigation or otherwise. The parties agree
10-K
hiqlidyn gpewwsr
22 Mar 19
Annual report
4:45pm
8-K
EX-99.1
pvl7l
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
DRS
EX-10.1
lz1044u5ct3
11 Oct 18
Draft registration statement
12:00am
8-K
EX-99.1
s0h70p
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
4vi g21j4aaq2rq6bh
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-99.1
g6t4eidh1caqk6
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
8-K
EX-99.1
828et3eyi ol23
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
FWP
7lh8 c722
18 May 20
Free writing prospectus
5:02pm
S-1/A
4ib7n3bfv6 u4
23 Jan 19
IPO registration (amended)
4:39pm
DRS
bfr2kjm8q
11 Oct 18
Draft registration statement
12:00am
S-1
EX-10.1
nwsr2u
21 Dec 18
IPO registration
4:39pm